Imagine you’re a business owner with a suggestion box in your store. Every week you gather those cards from the box and read through them. And week after week, two
Luminai Raises $38M With Cleveland Clinic Using Its AI for Hospital Operations
Another AI startup helping providers automate administrative processes picked up a significant round of capital on Thursday. San Francisco-based Luminai snagged $38 million in Series B funding, bringing its fundraising
Which Health Plans Rank Highest In Digital Experience?
Cigna Healthcare leads the way in digital experience among commercial health plans, while UPMC Health Plan ranks highest among Medicare Advantage plans, according to a new report from JD Power.
AI-Driven Precision Care is the Fix for Our Health System’s Failures
Every primary care physician knows the moment. A patient – say, a 60-year-old woman who suffers from heart failure and diabetes – is seeking treatment for a headache, fever, or
Insurers have Cut Prior Auth by 11% Following Commitments
In June of 2025, health plans made a series of commitments to improve prior authorization. On Tuesday, insurer advocacy organization AHIP and Blue Cross Blue Shield Association gave their first
Trial Failure in the Skin Does Not Dent Insmed Drug’s Potential in the Lungs
Insmed’s new drug, Brinsupri, is still projected to reach blockbuster status, but an inflammatory skin disorder is no longer in the picture following a mid-stage clinical trial failure in this
It’s Time to Put Guardrails on GLP-1 Compounding
If ever there was a time for federal regulators and lawmakers to ensure that all medications are safe, contain high-quality ingredients, and are held to rigorous production standards, it would
Do Healthcare CEOs Agree on Whether VBC and MA Actually Save Money?
Value-based care and Medicare Advantage are often heralded as two of healthcare’s most promising strategies for controlling costs, but industry leaders can’t quite tell if they’re actually working. During a
Gilead’s Pipeline Strategy Takes Shape With $3B Acquisition of Cancer Biotech Tubulis
Gilead Sciences is building out its pipeline through a multi-billion dollar deal to acquire Tubulis, a startup with two targeted therapies in clinical testing. While those therapies are in development
Women’s Health Is Central to the Future of Digital Health
Modern healthcare is increasingly powered by data — but much of that data was never designed to reflect half the population. When the data is incomplete or unbalanced, even the









